Yuanqi Pharmaceutical Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

Yuanqi Pharmaceutical General Information

Description

Developer of biotechnology products intended to treat inflammatory and immune diseases. The company offers a gut-enriched aryl hydrocarbon receptor agonist, small-molecule immunology drugs, inflammatory disease therapeutics, ulcerative colitis treatments, immune homeostasis regulators, and mucosal barrier repair agents, providing a new treatment option for patients with moderate to severe ulcerative colitis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 101, Building 1, Area B
  • Phase III Project
  • Suzhou, Jiangsu 215123
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Unit 101, Building 1, Area B
  • Phase III Project
  • Suzhou, Jiangsu 215123
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yuanqi Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 17-Jun-2022 Completed Generating Revenue
1. Seed Round 26-Jan-2021 Completed Startup
To view Yuanqi Pharmaceutical’s complete valuation and funding history, request access »

Yuanqi Pharmaceutical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
DHLT Investment Growth/Expansion Minority
Highlight Capital Venture Capital Minority
Zeyue Venture Capital Venture Capital Minority
AnlongMed Venture Capital Minority
BOHE Angel Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Yuanqi Pharmaceutical FAQs

  • When was Yuanqi Pharmaceutical founded?

    Yuanqi Pharmaceutical was founded in 2020.

  • Where is Yuanqi Pharmaceutical headquartered?

    Yuanqi Pharmaceutical is headquartered in Suzhou, China.

  • What industry is Yuanqi Pharmaceutical in?

    Yuanqi Pharmaceutical’s primary industry is Drug Discovery.

  • Is Yuanqi Pharmaceutical a private or public company?

    Yuanqi Pharmaceutical is a Private company.

  • What is Yuanqi Pharmaceutical’s current revenue?

    The current revenue for Yuanqi Pharmaceutical is .

  • How much funding has Yuanqi Pharmaceutical raised over time?

    Yuanqi Pharmaceutical has raised $15.4M.

  • Who are Yuanqi Pharmaceutical’s investors?

    DHLT Investment, Highlight Capital, Zeyue Venture Capital, AnlongMed, and BOHE Angel Fund are 5 of 6 investors who have invested in Yuanqi Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process